Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cancer research 2024-02, Vol.30 (3), p.639-639
Hauptverfasser:	Bhatia, Ankush, Moreno, Raquel, Reiner, Anne S, Nandakumar, Subhiksha, Walch, Henry S, Malani, Rachna, Panageas, Katherine S, Mellinghoff, Ingo K, Bale, Tejus A, Young, Robert J
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Brain Neoplasms - genetics Brain Neoplasms - pathology Glioma - genetics Glioma - pathology Humans Isocitrate Dehydrogenase - genetics Mutation Tumor Burden
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	639
container_issue	3
container_start_page	639
container_title	Clinical cancer research
container_volume	30
creator	Bhatia, Ankush Moreno, Raquel Reiner, Anne S Nandakumar, Subhiksha Walch, Henry S Malani, Rachna Panageas, Katherine S Mellinghoff, Ingo K Bale, Tejus A Young, Robert J
description
doi_str_mv	10.1158/1078-0432.CCR-23-3603
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2921117325</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2921117325</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-48d059eaf49b8b7e4fb30d0dd0b6fa4e1bacf572cd3baad7e51571cc7d03ad73</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhoMobk5_gpJLbzLz2bSXUuc2GAhzeBvSJtVK09SkRfz3tmx6dd4Dz3sOPADcErwkRKQPBMsUYc7oMs_3iDLEEszOwJwIIRGjiTgf8x8zA1cxfmJMOMH8EsxYSrOUcDoH-WFwPsA33wzOwnXw3_0H1BG-DiH4d91buGpN5-u2h3ULt08b5Hq4bmrvNNrb2Pk22mtwUekm2pvTXIDD8-qQb9DuZb3NH3eoZCLpEU8NFpnVFc-KtJCWVwXDBhuDi6TS3JJCl5WQtDSs0NpIK4iQpCylwWxc2QLcH892wX8NNvbK1bG0TaNb64eoaEYJIZJRMaLiiJbBxxhspbpQOx1-FMFq0qcmNWpSo0Z9ijI16Rt7d6cXQ-Gs-W_9-WK_OCJriA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2921117325</pqid></control><display><type>article</type><title>Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Bhatia, Ankush ; Moreno, Raquel ; Reiner, Anne S ; Nandakumar, Subhiksha ; Walch, Henry S ; Malani, Rachna ; Panageas, Katherine S ; Mellinghoff, Ingo K ; Bale, Tejus A ; Young, Robert J</creator><creatorcontrib>Bhatia, Ankush ; Moreno, Raquel ; Reiner, Anne S ; Nandakumar, Subhiksha ; Walch, Henry S ; Malani, Rachna ; Panageas, Katherine S ; Mellinghoff, Ingo K ; Bale, Tejus A ; Young, Robert J</creatorcontrib><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-23-3603</identifier><identifier>PMID: 38298142</identifier><language>eng</language><publisher>United States</publisher><subject>Biomarkers ; Brain Neoplasms - genetics ; Brain Neoplasms - pathology ; Glioma - genetics ; Glioma - pathology ; Humans ; Isocitrate Dehydrogenase - genetics ; Mutation ; Tumor Burden</subject><ispartof>Clinical cancer research, 2024-02, Vol.30 (3), p.639-639</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-48d059eaf49b8b7e4fb30d0dd0b6fa4e1bacf572cd3baad7e51571cc7d03ad73</citedby><cites>FETCH-LOGICAL-c356t-48d059eaf49b8b7e4fb30d0dd0b6fa4e1bacf572cd3baad7e51571cc7d03ad73</cites><orcidid>0000-0003-3641-9287 ; 0000-0003-0258-3484 ; 0000-0002-1258-6112 ; 0000-0003-1188-350X ; 0000-0001-5292-2822 ; 0000-0002-6591-604X ; 0000-0002-7729-7418 ; 0000-0003-2038-8738 ; 0000-0002-4347-8149 ; 0000-0001-7003-3017</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3343,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38298142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhatia, Ankush</creatorcontrib><creatorcontrib>Moreno, Raquel</creatorcontrib><creatorcontrib>Reiner, Anne S</creatorcontrib><creatorcontrib>Nandakumar, Subhiksha</creatorcontrib><creatorcontrib>Walch, Henry S</creatorcontrib><creatorcontrib>Malani, Rachna</creatorcontrib><creatorcontrib>Panageas, Katherine S</creatorcontrib><creatorcontrib>Mellinghoff, Ingo K</creatorcontrib><creatorcontrib>Bale, Tejus A</creatorcontrib><creatorcontrib>Young, Robert J</creatorcontrib><title>Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><subject>Biomarkers</subject><subject>Brain Neoplasms - genetics</subject><subject>Brain Neoplasms - pathology</subject><subject>Glioma - genetics</subject><subject>Glioma - pathology</subject><subject>Humans</subject><subject>Isocitrate Dehydrogenase - genetics</subject><subject>Mutation</subject><subject>Tumor Burden</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kF1LwzAUhoMobk5_gpJLbzLz2bSXUuc2GAhzeBvSJtVK09SkRfz3tmx6dd4Dz3sOPADcErwkRKQPBMsUYc7oMs_3iDLEEszOwJwIIRGjiTgf8x8zA1cxfmJMOMH8EsxYSrOUcDoH-WFwPsA33wzOwnXw3_0H1BG-DiH4d91buGpN5-u2h3ULt08b5Hq4bmrvNNrb2Pk22mtwUekm2pvTXIDD8-qQb9DuZb3NH3eoZCLpEU8NFpnVFc-KtJCWVwXDBhuDi6TS3JJCl5WQtDSs0NpIK4iQpCylwWxc2QLcH892wX8NNvbK1bG0TaNb64eoaEYJIZJRMaLiiJbBxxhspbpQOx1-FMFq0qcmNWpSo0Z9ijI16Rt7d6cXQ-Gs-W_9-WK_OCJriA</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Bhatia, Ankush</creator><creator>Moreno, Raquel</creator><creator>Reiner, Anne S</creator><creator>Nandakumar, Subhiksha</creator><creator>Walch, Henry S</creator><creator>Malani, Rachna</creator><creator>Panageas, Katherine S</creator><creator>Mellinghoff, Ingo K</creator><creator>Bale, Tejus A</creator><creator>Young, Robert J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3641-9287</orcidid><orcidid>https://orcid.org/0000-0003-0258-3484</orcidid><orcidid>https://orcid.org/0000-0002-1258-6112</orcidid><orcidid>https://orcid.org/0000-0003-1188-350X</orcidid><orcidid>https://orcid.org/0000-0001-5292-2822</orcidid><orcidid>https://orcid.org/0000-0002-6591-604X</orcidid><orcidid>https://orcid.org/0000-0002-7729-7418</orcidid><orcidid>https://orcid.org/0000-0003-2038-8738</orcidid><orcidid>https://orcid.org/0000-0002-4347-8149</orcidid><orcidid>https://orcid.org/0000-0001-7003-3017</orcidid></search><sort><creationdate>20240201</creationdate><title>Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response</title><author>Bhatia, Ankush ; Moreno, Raquel ; Reiner, Anne S ; Nandakumar, Subhiksha ; Walch, Henry S ; Malani, Rachna ; Panageas, Katherine S ; Mellinghoff, Ingo K ; Bale, Tejus A ; Young, Robert J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-48d059eaf49b8b7e4fb30d0dd0b6fa4e1bacf572cd3baad7e51571cc7d03ad73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomarkers</topic><topic>Brain Neoplasms - genetics</topic><topic>Brain Neoplasms - pathology</topic><topic>Glioma - genetics</topic><topic>Glioma - pathology</topic><topic>Humans</topic><topic>Isocitrate Dehydrogenase - genetics</topic><topic>Mutation</topic><topic>Tumor Burden</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhatia, Ankush</creatorcontrib><creatorcontrib>Moreno, Raquel</creatorcontrib><creatorcontrib>Reiner, Anne S</creatorcontrib><creatorcontrib>Nandakumar, Subhiksha</creatorcontrib><creatorcontrib>Walch, Henry S</creatorcontrib><creatorcontrib>Malani, Rachna</creatorcontrib><creatorcontrib>Panageas, Katherine S</creatorcontrib><creatorcontrib>Mellinghoff, Ingo K</creatorcontrib><creatorcontrib>Bale, Tejus A</creatorcontrib><creatorcontrib>Young, Robert J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhatia, Ankush</au><au>Moreno, Raquel</au><au>Reiner, Anne S</au><au>Nandakumar, Subhiksha</au><au>Walch, Henry S</au><au>Malani, Rachna</au><au>Panageas, Katherine S</au><au>Mellinghoff, Ingo K</au><au>Bale, Tejus A</au><au>Young, Robert J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>30</volume><issue>3</issue><spage>639</spage><epage>639</epage><pages>639-639</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><cop>United States</cop><pmid>38298142</pmid><doi>10.1158/1078-0432.CCR-23-3603</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3641-9287</orcidid><orcidid>https://orcid.org/0000-0003-0258-3484</orcidid><orcidid>https://orcid.org/0000-0002-1258-6112</orcidid><orcidid>https://orcid.org/0000-0003-1188-350X</orcidid><orcidid>https://orcid.org/0000-0001-5292-2822</orcidid><orcidid>https://orcid.org/0000-0002-6591-604X</orcidid><orcidid>https://orcid.org/0000-0002-7729-7418</orcidid><orcidid>https://orcid.org/0000-0003-2038-8738</orcidid><orcidid>https://orcid.org/0000-0002-4347-8149</orcidid><orcidid>https://orcid.org/0000-0001-7003-3017</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1078-0432
ispartof	Clinical cancer research, 2024-02, Vol.30 (3), p.639-639
issn	1078-0432 1557-3265
language	eng
recordid	cdi_proquest_miscellaneous_2921117325
source	MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects	Biomarkers Brain Neoplasms - genetics Brain Neoplasms - pathology Glioma - genetics Glioma - pathology Humans Isocitrate Dehydrogenase - genetics Mutation Tumor Burden
title	Tumor Volume Growth as Surrogate Endpoint in IDH-mt Glioma-Response
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T17%3A00%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20Volume%20Growth%20as%20Surrogate%20Endpoint%20in%20IDH-mt%20Glioma-Response&rft.jtitle=Clinical%20cancer%20research&rft.au=Bhatia,%20Ankush&rft.date=2024-02-01&rft.volume=30&rft.issue=3&rft.spage=639&rft.epage=639&rft.pages=639-639&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-23-3603&rft_dat=%3Cproquest_cross%3E2921117325%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2921117325&rft_id=info:pmid/38298142&rfr_iscdi=true